- Home
- BIOX vs RAPT Comparison
BIOX vs RAPT Comparison
Compare BIOX & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- RAPT
- Stock Information
- Founded
- BIOX 2001
- RAPT 2015
- Country
- BIOX Argentina
- RAPT United States
- Employees
- BIOX N/A
- RAPT N/A
- Industry
- BIOX Agricultural Chemicals
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- BIOX Industrials
- RAPT Health Care
- Exchange
- BIOX Nasdaq
- RAPT Nasdaq
- Market Cap
- BIOX 168.3M
- RAPT 194.2M
- IPO Year
- BIOX N/A
- RAPT 2019
- Fundamental
- Price
- BIOX $2.77
- RAPT $11.38
- Analyst Decision
- BIOX Strong Buy
- RAPT Buy
- Analyst Count
- BIOX 4
- RAPT 5
- Target Price
- BIOX $8.38
- RAPT $33.60
- AVG Volume (30 Days)
- BIOX 279.5K
- RAPT 107.8K
- Earning Date
- BIOX 09-08-2025
- RAPT 08-07-2025
- Dividend Yield
- BIOX N/A
- RAPT N/A
- EPS Growth
- BIOX N/A
- RAPT N/A
- EPS
- BIOX N/A
- RAPT N/A
- Revenue
- BIOX $383,289,394.00
- RAPT N/A
- Revenue This Year
- BIOX N/A
- RAPT N/A
- Revenue Next Year
- BIOX $7.30
- RAPT N/A
- P/E Ratio
- BIOX N/A
- RAPT N/A
- Revenue Growth
- BIOX N/A
- RAPT N/A
- 52 Week Low
- BIOX $2.60
- RAPT $5.67
- 52 Week High
- BIOX $11.39
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- BIOX 35.91
- RAPT 54.94
- Support Level
- BIOX $2.63
- RAPT $10.06
- Resistance Level
- BIOX $2.89
- RAPT $11.65
- Average True Range (ATR)
- BIOX 0.19
- RAPT 0.88
- MACD
- BIOX 0.02
- RAPT 0.02
- Stochastic Oscillator
- BIOX 30.77
- RAPT 77.43
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.